HistoSonics Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Private

  • Employees
  • 182

Employees

  • Latest Deal Type
  • Series D

  • Latest Deal Amount
  • $102M

  • Investors
  • 24

HistoSonics General Information

Description

Developer of a novel, non-invasive sonic beam therapy platform designed to liquefy and destroy targeted tissues at a sub-cellular level. The company's platform delivers personalized, tissue-specific treatments with unparalleled precision and control and without the undesirable side effects of many of today's interventional and surgical modalities, enabling physicians to monitor the treatment and its effect in real time continuously.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 16305 36th Avenue North
  • Suite 300
  • Plymouth, MN 55446
  • United States
+1 (877)
Primary Industry
Surgical Devices
Other Industries
Other Healthcare Services
Corporate Office
  • 16305 36th Avenue North
  • Suite 300
  • Plymouth, MN 55446
  • United States
+1 (877)

HistoSonics Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

HistoSonics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC (Series D) 15-Aug-2024 $102M Completed Generating Revenue
7. Later Stage VC (Series D) 13-Dec-2022 Completed Generating Revenue
6. Later Stage VC (Series C1) 15-Apr-2020 Completed Generating Revenue
5. Later Stage VC (Series C) 05-Apr-2019 Completed Generating Revenue
4. Later Stage VC (Series B) 08-Feb-2017 Completed Generating Revenue
3. Debt - General 01-Dec-2015 Completed Generating Revenue
2. Later Stage VC (Series A) 16-May-2014 $14.2M $14.2M Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2010 Completed Startup
To view HistoSonics’s complete valuation and funding history, request access »

HistoSonics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series D-1
Series D-2
Series C1
Series C
Series B 25,110,459 $0.001000 $0.04 $0.55 $0.55 1x $0.55 6.57%
Series A 16,262,314 $0.001000 $0.06 $1 $1 1x $1 4.25%
To view HistoSonics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

HistoSonics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a novel, non-invasive sonic beam therapy platform designed to liquefy and destroy targeted tissues at a sub
Surgical Devices
Plymouth, MN
182 As of 2024

Mississauga, Canada
 

Hayward, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

HistoSonics Competitors (7)

One of HistoSonics’s 7 competitors is Profound Medical, a Formerly VC-backed company based in Mississauga, Canada.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Profound Medical Formerly VC-backed Mississauga, Canada
RefleXion (Biotechnology) Venture Capital-Backed Hayward, CA
Insightec Venture Capital-Backed Tirat Carmel, Israel
ViewRay Formerly VC-backed Bedford, OH
Boston Scientific Corporation Marlborough, MA
You’re viewing 5 of 7 competitors. Get the full list »

HistoSonics Patents

HistoSonics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250090130-A1 Co-registration techniques between computed tomography imaging systems and histotripsy robotic systems Pending 19-Sep-2023
US-20250090871-A1 Simulation software and tools for evaluating histotripsy therapy for a given pose and position of a therapy array Pending 15-Sep-2023
US-20240350153-A1 Histotripsy systems and associated methods including user interfaces and workflows for treatment planning and therapy Pending 20-Apr-2023
US-D1065226-S1 Display screen or portion thereof with an animated graphical user interface Active 20-Apr-2023
US-D1065246-S1 Display screen or portion thereof with an animated graphical user interface Active 20-Apr-2023
To view HistoSonics’s complete patent history, request access »

HistoSonics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

HistoSonics Investors (24)

Investor Name Investor Type Holding Investor Since Participating Rounds
Amzak Health Venture Capital Minority
HealthQuest Capital Growth/Expansion Minority
Alpha Wave Global Growth/Expansion Minority
Gary Comer PE/Buyout Minority
Trout Creek Ventures Venture Capital Minority
You’re viewing 5 of 24 investors. Get the full list »

HistoSonics FAQs

  • When was HistoSonics founded?

    HistoSonics was founded in 2009.

  • Where is HistoSonics headquartered?

    HistoSonics is headquartered in Plymouth, MN.

  • What is the size of HistoSonics?

    HistoSonics has 182 total employees.

  • What industry is HistoSonics in?

    HistoSonics’s primary industry is Surgical Devices.

  • Is HistoSonics a private or public company?

    HistoSonics is a Private company.

  • What is the current valuation of HistoSonics?

    The current valuation of HistoSonics is .

  • What is HistoSonics’s current revenue?

    The current revenue for HistoSonics is .

  • How much funding has HistoSonics raised over time?

    HistoSonics has raised $329M.

  • Who are HistoSonics’s investors?

    Amzak Health, HealthQuest Capital, Alpha Wave Global, Gary Comer, and Trout Creek Ventures are 5 of 24 investors who have invested in HistoSonics.

  • Who are HistoSonics’s competitors?

    Profound Medical, RefleXion (Biotechnology), Insightec, ViewRay, and Boston Scientific are some of the 7 competitors of HistoSonics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »